EQRx, Inc. – NASDAQ:EQRXW

Add to watchlist

Market closed

Open in about 13 hours

+15.00%

month

-53.01%

quarter

-95.40%

year

Market Cap	1.14B
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	-0.16

Revenue	N/A
EBITDA	-290.06M
Income	-83.79M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

EQRx, Inc. (NASDAQ:EQRXW): Profit margin
Dec 2022	0	135.09M
Mar 2023	0	-63.30M
Jun 2023	0	-72.95M
Sep 2023	0	-82.63M

EQRx, Inc. (NASDAQ:EQRXW): Debt to assets
Dec 2022	1455016000	66.15M	4.55%
Mar 2023	1383955000	69.64M	5.03%
Jun 2023	1311398000	63.08M	4.81%
Sep 2023	1240290000	69.37M	5.59%

EQRx, Inc. (NASDAQ:EQRXW): Cash Flow
Dec 2022	-105.79M	-398.41M	327
Mar 2023	-85.54M	-40.35M	127K
Jun 2023	-76.89M	-44.04M	74K
Sep 2023	-61.90M	129.87M	209K

EQRx alternative data

EQRx, Inc. (NASDAQ:EQRXW): Employee count
Aug 2023	216
Sep 2023	216
Oct 2023	216
Nov 2023	216
Dec 2023	216
Jan 2024	216
Feb 2024	216
Mar 2024	216
Apr 2024	216
May 2024	216
Jun 2024	216
Jul 2024	216

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	17 Dec 2021	CASDIN ELI director, 10 percent owner director, 10 percent owner	Class B Common Stock	8,659,372	N/A	N/A
Option	17 Dec 2021	CASDIN ELI director, 10 percent owner director, 10 percent owner	Class A Common Stock	8,659,372	N/A	N/A
Option	17 Dec 2021	ABERNETHY AMY director director	Class B Common Stock	200,000	N/A	N/A
Option	17 Dec 2021	ABERNETHY AMY director director	Class A Common Stock	200,000	N/A	N/A

Ideas & Opinions

Seeking Alpha 8 Sep 2022

Checkpoint: Strong Data, But Comes With Risks

Frequently Asked Questions (FAQ)

When is EQRx's next earnings date?

Unfortunately, EQRx's (EQRXW) next earnings date is currently unknown.
Does EQRx pay dividends?

No, EQRx does not pay dividends.
How much money does EQRx make?

EQRx has a market capitalization of 1.14B.
What is EQRx's stock symbol?

EQRx, Inc. is traded on the NASDAQ under the ticker symbol "EQRXW".
What is EQRx's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of EQRx?

Shares of EQRx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How many employees does EQRx have?

As Jul 2024, EQRx employs 216 workers.
When EQRx went public?

EQRx, Inc. is publicly traded company for more then 3 years since IPO on 20 Dec 2021.
What is EQRx's official website?

The official website for EQRx is eqrx.com.
Where are EQRx's headquarters?

EQRx is headquartered at 50 Hampshire Street, Cambridge, MA.
How can i contact EQRx?

EQRx's mailing address is 50 Hampshire Street, Cambridge, MA and company can be reached via phone at +61 73152255.

EQRx, Inc.

eqrx.com

Exchange:

NASDAQ

Full time employees:

216

Industry:

Biotechnology

Sector:

Healthcare

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. Its product pipeline in development includes Aumolertinib, an EGFR inhibitor for the treatment of ?EGFR-mutated? non-small cell lung cancer (NSCLC); Sugemalimab, an anti-PD-L1 antibody for the treatment of ?stage III and IV ?NSCLC; Lerociclib, a CDK4/6 inhibitor to treat HR+/HER2- breast cancer; and EQ176, an anti-PD-1?antibody for the treatment of liver cancer. The company has partnerships with Exscientia and AbCellera Biologics Inc. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts.

+61 73152255

50 Hampshire Street
Cambridge, MA 02139

CIK: 0001843762
:
CUSIP: 26886C115